Scarica l'app Stockscreener
1.63
4.68%
-0.08
Dopo l'orario di chiusura:
1.63
Precedente Chiudi:
$1.71
Aprire:
$1.71
Volume 24 ore:
154.19K
Relative Volume:
0.13
Capitalizzazione di mercato:
$100.06M
Reddito:
$5.03M
Utile/perdita netta:
$-185.41M
Rapporto P/E:
-0.5275
EPS:
-3.09
Flusso di cassa netto:
$-139.79M
1 W Prestazione:
+0.62%
1M Prestazione:
-4.12%
6M Prestazione:
+20.74%
1 anno Prestazione:
-87.29%
Intervallo 1D:
$1.60
$1.71
Intervallo di 1 settimana:
$1.54
$1.73
Portata 52W:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Nome
Pliant Therapeutics Inc
Settore
Industria
Telefono
650-481-6770
Indirizzo
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Confronta PLRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.63 | 102.83M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Ripresa | Cantor Fitzgerald | Neutral |
| 2025-03-04 | Downgrade | Needham | Buy → Hold |
| 2025-03-03 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | Downgrade | Stifel | Buy → Hold |
| 2025-02-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | Downgrade | Citigroup | Buy → Neutral |
| 2025-02-10 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-02-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | Ripresa | Leerink Partners | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-05-18 | Iniziato | Canaccord Genuity | Buy |
| 2023-04-13 | Iniziato | Robert W. Baird | Outperform |
| 2022-12-14 | Iniziato | Stifel | Buy |
| 2022-12-07 | Iniziato | JP Morgan | Overweight |
| 2022-09-01 | Iniziato | Citigroup | Buy |
| 2022-07-20 | Iniziato | SVB Leerink | Outperform |
| 2022-05-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-03 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-20 | Iniziato | BTIG Research | Buy |
| 2021-04-05 | Iniziato | Citigroup | Buy |
| 2020-06-29 | Iniziato | Citigroup | Buy |
| 2020-06-29 | Iniziato | Cowen | Outperform |
| 2020-06-29 | Iniziato | Needham | Buy |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie
Does Pliant Therapeutics Inc. stock have upside surprise potentialJuly 2025 PostEarnings & Weekly Breakout Watchlists - khodrobank.com
How cyclical is Pliant Therapeutics Inc.’s revenue stream2025 Retail Activity & Capital Efficiency Focused Ideas - khodrobank.com
Pliant Therapeutics Inc. stock trendline breakdownWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Live market analysis of Pliant Therapeutics IncJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
What Fibonacci levels say about Pliant Therapeutics Inc. rebound2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Pliant Therapeutics Inc. stock split in the near future2025 Top Decliners & AI Powered Trade Plan Recommendations - Newser
Pliant Therapeutics Inc. stock volume spike explainedQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Analyzing drawdowns of Pliant Therapeutics Inc. with statistical toolsQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser
How to use Fibonacci retracement on Pliant Therapeutics Inc.New Guidance & Free Technical Pattern Based Buy Signals - Newser
How to forecast Pliant Therapeutics Inc. trends using time seriesMarket Weekly Review & Momentum Based Trading Ideas - Newser
Live market analysis of Pliant Therapeutics Inc.Trade Entry Summary & Entry Point Strategy Guides - Newser
Sentiment analysis tools applied to Pliant Therapeutics Inc.2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Institutional scanner results for Pliant Therapeutics Inc.Dollar Strength & AI Based Buy and Sell Signals - Newser
What’s next for Pliant Therapeutics Inc. stock priceOil Prices & Risk Managed Investment Signals - Newser
Why Pliant Therapeutics Inc. is moving todayWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Is Pliant Therapeutics Inc. stock entering bullish territoryJuly 2025 Recap & Capital Efficiency Focused Ideas - Newser
Can swing trading help recover from Pliant Therapeutics Inc. lossesTrade Risk Assessment & Precise Trade Entry Recommendations - Newser
Can Pliant Therapeutics Inc. rally from current levelsQuarterly Trade Summary & Fast Entry High Yield Tips - Newser
Sector ETF performance correlation with Pliant Therapeutics Inc.July 2025 Selloffs & Risk Managed Investment Strategies - Newser
Strategies to average down on Pliant Therapeutics Inc.2025 Sector Review & Safe Entry Point Alerts - Newser
Is Pliant Therapeutics Inc. stock poised for growthMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
How to recover losses in Pliant Therapeutics Inc. stockQuarterly Growth Report & Accurate Trade Setup Notifications - Newser
Will Pliant Therapeutics Inc. announce a stock splitProfit Target & Low Risk High Reward Trade Ideas - khodrobank.com
How to track smart money flows in Pliant Therapeutics Inc.Market Trend Review & Free Technical Confirmation Trade Alerts - Newser
Published on: 2025-09-02 05:09:14 - Newser
Is Pliant Therapeutics Inc. currently under institutional pressureBreakout Watch & Accurate Technical Buy Alerts - khodrobank.com
Pliant Therapeutics Inc. stock trend outlook and recovery pathTrade Risk Assessment & AI Based Buy/Sell Signal Reports - Newser
How liquid is Pliant Therapeutics Inc. stockPortfolio Performance Summary & Growth Focused Stock Pick Reports - khodrobank.com
Has Pliant Therapeutics Inc. formed a bullish divergenceVolume Spike & Precise Buy Zone Identification - Newser
What machine learning models say about Pliant Therapeutics Inc.2025 Retail Activity & Real-Time Price Movement Reports - Newser
Pliant Therapeutics Inc.’s volatility index tracking explainedBull Run & Consistent Return Strategy Ideas - Newser
Does Pliant Therapeutics Inc. have declining or rising EPSJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - khodrobank.com
Pliant Therapeutics Inc. Matches Institutional Buying FilterJuly 2025 Momentum & Community Verified Watchlist Alerts - beatles.ru
How to monitor Pliant Therapeutics Inc. with trend dashboards2025 Trading Volume Trends & High Accuracy Swing Trade Signals - Newser
How to build a custom watchlist for Pliant Therapeutics Inc.2025 Major Catalysts & High Conviction Trade Alerts - Newser
Ranking Pliant Therapeutics Inc. among high performing stocks via toolsMarket Trend Report & Long-Term Capital Growth Ideas - Newser
Identifying reversal signals in Pliant Therapeutics Inc.July 2025 Movers & Reliable Entry Point Alerts - Newser
Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pliant Therapeutics Inc Azioni (PLRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cummings Keith Lamont | Chief Financial Officer |
Jan 17 '25 |
Sale |
11.20 |
20,148 |
225,680 |
262,608 |
| Hull Hans | Chief Business Officer |
Jan 17 '25 |
Sale |
11.20 |
15,936 |
178,501 |
211,558 |
| Lefebvre Eric | Chief Medical Officer |
Jan 17 '25 |
Sale |
11.20 |
18,478 |
206,974 |
194,574 |
| Cheung Lily | Chief Human Resource Officer |
Jan 17 '25 |
Sale |
11.20 |
3,740 |
41,892 |
24,550 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 17 '25 |
Sale |
11.20 |
13,270 |
148,639 |
80,774 |
| Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 22 '25 |
Sale |
10.99 |
10,230 |
112,462 |
70,544 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):